|
PL1814580T3
(pl)
|
2004-11-24 |
2017-03-31 |
Fred Hutchinson Cancer Research Center |
Metody stosowania il-21 do adoptywnej immunoterapii i identyfikacji antygenów guza
|
|
GB201506423D0
(en)
|
2015-04-15 |
2015-05-27 |
Tc Biopharm Ltd |
Gamma delta T cells and uses thereof
|
|
JP7146397B2
(ja)
|
2014-11-17 |
2022-10-04 |
アディセット バイオ， インコーポレイテッド |
改変γδＴ細胞
|
|
SG11201706128PA
(en)
|
2015-01-27 |
2017-08-30 |
Lava Therapeutics B V |
Single domain antibodies targeting cd1d
|
|
GB201507368D0
(en)
|
2015-04-30 |
2015-06-17 |
Ucl Business Plc |
Cell
|
|
KR102663157B1
(ko)
*
|
2015-06-09 |
2024-05-13 |
감마델타 테라퓨틱스 엘티디 |
Ｔｃｒ감마 델타 양성 ｔ 세포의 생산 방법
|
|
WO2017041106A1
(en)
|
2015-09-03 |
2017-03-09 |
The Uab Research Foundation |
Genetically-engineered drug resistant t cells and methods of using the same
|
|
CN118421557A
(zh)
*
|
2016-05-12 |
2024-08-02 |
阿迪塞特治疗公司 |
选择性扩增γδT细胞群的方法及其组合物
|
|
US10426796B2
(en)
*
|
2016-06-13 |
2019-10-01 |
SMART SURGICAL, Inc. |
Compositions for biological systems and methods for preparing and using the same
|
|
US10456423B2
(en)
|
2016-06-13 |
2019-10-29 |
SMART SURGICAL, Inc. |
Compositions for biological systems and methods for preparing and using the same
|
|
JP7193862B2
(ja)
|
2016-08-03 |
2022-12-21 |
ワシントン・ユニバーシティ |
キメラ抗原受容体でのｔ細胞性悪性腫瘍の治療のためのｃａｒ－ｔ細胞の遺伝子編集
|
|
KR102032354B1
(ko)
|
2016-11-11 |
2019-10-16 |
가톨릭대학교 산학협력단 |
신규한 배양보조세포 및 이를 이용한 감마 델타 ｔ 세포의 증식 방법
|
|
EP3544996A2
(en)
|
2016-11-22 |
2019-10-02 |
TCR2 Therapeutics Inc. |
Compositions and methods for tcr reprogramming using fusion proteins
|
|
AU2017382902A1
(en)
*
|
2016-12-21 |
2019-07-18 |
TCR2 Therapeutics Inc. |
Engineered T cells for the treatment of cancer
|
|
SG10202107136XA
(en)
*
|
2017-02-08 |
2021-07-29 |
Agency Science Tech & Res |
Gamma delta t cells and a method of augmenting the tumoricidal activity of the same
|
|
AU2018234827B2
(en)
|
2017-03-15 |
2024-04-04 |
Orca Biosystems Inc. |
Compositions and methods for hematopoietic stem cell transplants
|
|
GB201707048D0
(en)
*
|
2017-05-03 |
2017-06-14 |
King S College London |
Expansion of gamma delta cells, compositions, and methods of use thereof
|
|
US12384830B2
(en)
*
|
2017-06-02 |
2025-08-12 |
Regents Of The University Of Minnesota |
Compositions and methods for improving immunotherapy
|
|
WO2018236986A1
(en)
*
|
2017-06-20 |
2018-12-27 |
The Trustees Of Columbia University In The City Of New York |
Engineered t-cell receptors and methods of their use
|
|
CA3066779A1
(en)
|
2017-06-28 |
2019-01-03 |
Regeneron Pharmaceuticals, Inc. |
Anti-human papillomavirus (hpv) antigen-binding proteins and methods of use thereof
|
|
EP4467146A3
(en)
*
|
2017-09-15 |
2025-05-07 |
King's College London |
Compositions and methods for enhancing gamma delta t cells in the gut
|
|
TWI687227B
(zh)
*
|
2017-10-03 |
2020-03-11 |
生倍科技股份有限公司 |
用於t細胞免疫療法之組合及其用途
|
|
CN109777778B
(zh)
*
|
2017-11-14 |
2023-07-18 |
中国科学院广州生物医药与健康研究院 |
一种基因改造的γδT细胞
|
|
KR20200098518A
(ko)
|
2017-11-15 |
2020-08-20 |
아디셋 바이오, 인크. |
δ3 γδ T-세포 집단의 선택적 증식을 위한 방법 및 이의 조성물
|
|
DE102017127984B4
(de)
|
2017-11-27 |
2019-12-05 |
Immatics US, Inc. |
Verfahren für die Vermehrung und Aktivierung von γδ-T-Zellen
|
|
CN108129566B
(zh)
*
|
2017-12-31 |
2021-05-11 |
中国科学院武汉病毒研究所 |
靶向间皮素的c-型单域抗体及其制备方法与应用
|
|
US12215154B2
(en)
|
2018-01-19 |
2025-02-04 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for targeting γδ T cells with chimeric antigen receptors
|
|
WO2019178463A1
(en)
*
|
2018-03-16 |
2019-09-19 |
H. Lee Moffitt Cancer Center And Research Institute Inc. |
Chimeric antigen receptors with mutated cd28 phosphorylation sites
|
|
GB201804701D0
(en)
|
2018-03-23 |
2018-05-09 |
Gammadelta Therapeutics Ltd |
Lymphocytes expressing heterologous targeting constructs
|
|
EP3792347A4
(en)
*
|
2018-05-08 |
2021-11-10 |
Osaka University |
METHOD FOR PRODUCING HOMOCYGOTIC CELLS
|
|
CN110577932A
(zh)
*
|
2018-06-07 |
2019-12-17 |
亘喜生物科技（上海）有限公司 |
一种脐带血来源的嵌合抗原受体t细胞
|
|
WO2020018695A1
(en)
*
|
2018-07-18 |
2020-01-23 |
Amgen Inc. |
Chimeric receptors to steap1 and methods of use thereof
|
|
EP4650007A2
(en)
*
|
2018-08-01 |
2025-11-19 |
Imcheck Therapeutics |
Anti-btn3a antibodies and their use in treating cancer or infectious disorders
|
|
CN108949685B
(zh)
*
|
2018-08-02 |
2022-03-29 |
吉林大学第一医院 |
一种体外诱导扩增高杀伤活性γδT细胞的方法
|
|
WO2020033464A1
(en)
|
2018-08-07 |
2020-02-13 |
H. Lee Moffitt Cancer Center And Research Institute Inc. |
Car t-cells for the treatment of bone metastatic cancer
|
|
US20210177903A1
(en)
*
|
2018-08-07 |
2021-06-17 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Car t-cells for the treatment of bone metastatic cancer
|
|
CN112105724A
(zh)
*
|
2018-08-09 |
2020-12-18 |
深圳华大生命科学研究院 |
无内源hla基因背景的抗原递呈细胞系的构建方法、抗原递呈细胞系及其用途
|
|
ES2996944T3
(en)
*
|
2018-08-10 |
2025-02-13 |
Univ Kyoto |
Method for producing cd3-positive cell
|
|
CN113307872B
(zh)
*
|
2018-08-11 |
2022-12-06 |
广东天科雅生物医药科技有限公司 |
一种工程化核酸、t细胞及其应用和产生方法
|
|
CN109161533B
(zh)
*
|
2018-08-28 |
2020-07-24 |
深圳市菲鹏生物制药股份有限公司 |
无血清培养组合物及其应用
|
|
US12077586B2
(en)
|
2018-09-19 |
2024-09-03 |
LAVA Therapeutics N.V. |
Bispecific antibodies for use in the treatment of hematological malignancies
|
|
CA3115139A1
(en)
*
|
2018-10-01 |
2020-04-09 |
Adicet Bio Inc. |
Compositions and methods regarding engineered and non-engineered .gamma..delta.-t cells for treatment of hematological tumors
|
|
AU2019354395A1
(en)
|
2018-10-01 |
2021-05-06 |
Adicet Therapeutics, Inc. |
Compositions and methods regarding engineered and non-engineered γδ -T cells for treatment of solid tumors
|
|
US12331320B2
(en)
|
2018-10-10 |
2025-06-17 |
The Research Foundation For The State University Of New York |
Genome edited cancer cell vaccines
|
|
EA202191107A1
(ru)
|
2018-10-23 |
2021-09-17 |
Ридженерон Фармасьютикалз, Инк. |
T-клеточные рецепторы ny-eso-1 и способы их применения
|
|
GB201818243D0
(en)
|
2018-11-08 |
2018-12-26 |
Gammadelta Therapeutics Ltd |
Methods for isolating and expanding cells
|
|
BR112021010804A2
(pt)
*
|
2018-12-03 |
2021-11-16 |
Adicet Bio Inc |
Métodos para expansão seletiva in vivo de populações de células t gama delta e composições das mesmas
|
|
CN111544585B
(zh)
*
|
2019-02-11 |
2024-12-27 |
北京卡替医疗技术有限公司 |
一种可助推免疫细胞在体内扩增的佐剂
|
|
WO2020166729A1
(ja)
*
|
2019-02-14 |
2020-08-20 |
学校法人獨協学園獨協医科大学 |
Ｔ細胞ワクチン
|
|
WO2020172177A1
(en)
*
|
2019-02-18 |
2020-08-27 |
Memorial Sloan-Kettering Cancer Center |
Combinations of multiple chimeric antigen receptors for immunotherapy
|
|
IL285806B2
(en)
*
|
2019-02-24 |
2025-05-01 |
Gamida Cell Ltd |
Increasing the homing capacity of gamma-delta cells to produce cell compounds for therapeutic use
|
|
CA3128971A1
(en)
*
|
2019-03-08 |
2020-09-17 |
Klinikum Der Universitat Munchen |
Ccr8 expressing lymphocytes for targeted tumor therapy
|
|
CN109758590B
(zh)
*
|
2019-03-28 |
2022-02-11 |
广东工业大学 |
一种用于筛选人前列腺癌肿瘤抗原表位肽的方法
|
|
US20220282217A1
(en)
*
|
2019-03-30 |
2022-09-08 |
Biontech Us Inc. |
Compositions and methods for preparing t cell compositions and uses thereof
|
|
CN113811329B
(zh)
|
2019-04-19 |
2025-10-14 |
天科雅生物科技有限公司 |
抗pd-1抗体和其用途
|
|
EP3959236A4
(en)
*
|
2019-04-26 |
2023-01-25 |
The University of North Carolina at Chapel Hill |
CHIMERIC ANTIGEN RECEPTOR CONSTRUCTS AND THEIR USE IN CAR-T CELLS
|
|
JP7686571B2
(ja)
*
|
2019-05-08 |
2025-06-02 |
ヤンセン バイオテツク，インコーポレーテツド |
Ｔ細胞媒介性免疫を調節するための材料及び方法
|
|
US20230149457A1
(en)
*
|
2019-07-17 |
2023-05-18 |
Case Western Reserve University |
Long lived t cells for treating hiv infection
|
|
WO2021016652A1
(en)
*
|
2019-07-29 |
2021-02-04 |
The University Of Melbourne |
METHODS AND COMPOSITIONS FOR MONITORING, TREATING AND PREVENTING CMV INFECTION OR GRAFT REJECTION USING γδ T-CELLS
|
|
CA3145523A1
(en)
*
|
2019-08-16 |
2021-02-25 |
GammaDelta Therapeutics Limited |
Therapeutic uses of anti-tcr delta variable 1 antibodies
|
|
EP4045635A4
(en)
*
|
2019-10-17 |
2023-10-25 |
The University of Hong Kong |
METHODS FOR PREPARING EXOSOMES DERIVED FROM T-V LYMPHOCYTES FOR THE TREATMENT OF CANCERS ASSOCIATED WITH EPSTEIN-BARR VIRUS
|
|
IL292213A
(en)
|
2019-10-31 |
2022-06-01 |
Morphosys Ag |
Combination anti-tumor therapy including anti-cd19 antibody and gamma delta t cells
|
|
IL293459A
(en)
*
|
2019-12-03 |
2022-07-01 |
Adicet Bio Inc |
Methods for expanding γδ t-cell populations with multivalent agents and compositions thereof
|
|
JP2023511417A
(ja)
|
2020-01-24 |
2023-03-17 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
黒色腫において優先的に発現する抗原（ｐｒａｍｅ）ｔ細胞受容体およびそれらの使用方法
|
|
CR20220431A
(es)
*
|
2020-03-03 |
2023-02-21 |
Janssen Biotech Inc |
CÉLULAS T yo Y USOS DE ESTAS
|
|
JP2023524047A
(ja)
|
2020-04-28 |
2023-06-08 |
ライエル・イミュノファーマ・インコーポレイテッド |
細胞の培養方法
|
|
US20230226181A1
(en)
*
|
2020-06-22 |
2023-07-20 |
Nanjing Legend Biotech Co., Ltd. |
GENETIC ENGINEERING OF gamma delta T CELLS FOR IMMUNOTHERAPY
|
|
CA3188601A1
(en)
|
2020-07-08 |
2022-01-13 |
LAVA Therapeutics N.V. |
Antibodies that bind psma and gamma-delta t cell receptors
|
|
CN116083368A
(zh)
*
|
2020-07-14 |
2023-05-09 |
广州泛恩生物科技有限公司 |
基于tnfrsf9阳性t细胞的用于杀伤肿瘤的tcr-t细胞及其制备方法和应用
|
|
JP2024507735A
(ja)
*
|
2021-02-08 |
2024-02-21 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
ブチロフィリンサブファミリー３メンバーａ１（ｂｔｎ３ａ１、ｃｄ２７７）の制御
|
|
GB202105113D0
(en)
*
|
2021-04-09 |
2021-05-26 |
Gammadelta Therapeutics Ltd |
Novel method
|
|
EP4419118A4
(en)
*
|
2021-10-20 |
2025-04-30 |
University of Pittsburgh - Of the Commonwealth System of Higher Education |
Methods and materials for expanding tumor infiltrating gamma-delta t cells
|
|
WO2023092119A2
(en)
|
2021-11-22 |
2023-05-25 |
Ludwig Institute For Cancer Research Ltd |
Methods for predicting responsiveness to a cancer therapy
|
|
MX2024006821A
(es)
*
|
2021-12-05 |
2024-08-06 |
Adicet Therapeutics Inc |
Tratamiento de neoplasias malignas de celulas b.
|
|
KR20230105166A
(ko)
|
2022-01-03 |
2023-07-11 |
주식회사 이뮤노맥스 |
감마-델타 t 세포의 증식 배양 방법
|
|
CN114149978B
(zh)
*
|
2022-02-09 |
2022-04-26 |
深圳博雅感知药业有限公司 |
制备car-t细胞的方法
|
|
MX2024010047A
(es)
|
2022-02-16 |
2024-08-26 |
Priothera Sas |
Metodos de tratamiento con celulas car en combinacion con moduladores del receptor s1p.
|
|
GB202204926D0
(en)
|
2022-04-04 |
2022-05-18 |
Gammadelta Therapeutics Ltd |
Method for expanding gammadelta T cells
|
|
WO2023242434A1
(en)
*
|
2022-06-17 |
2023-12-21 |
Gadeta B.V. |
Modified immune cells
|
|
CN115624618A
(zh)
*
|
2022-09-16 |
2023-01-20 |
深圳善乐生物科技有限公司 |
一种HPV多肽抗原负载γδT细胞在HPV阳性宫颈癌免疫治疗中的应用
|
|
US20240148867A1
(en)
|
2022-10-31 |
2024-05-09 |
Regeneron Pharmaceuticals, Inc. |
Methods of treating cancer with a combination of adoptive cell therapy and a targeted immunocytokine
|
|
AU2024253044A1
(en)
|
2023-04-07 |
2025-10-02 |
Regeneron Pharmaceuticals, Inc. |
Methods of treating cancer with a lymphotoxin beta receptor agonist
|
|
WO2024243511A1
(en)
|
2023-05-25 |
2024-11-28 |
Regeneron Pharmaceuticals, Inc. |
T cell receptors that bind presented hpv16-, mart1-, cmv-, ebv-, or influenza- peptides
|
|
US12221483B1
(en)
*
|
2024-01-30 |
2025-02-11 |
China Medical University Hospital |
Fusion protein and nucleic acid encoding sequence thereof, and uses of the same
|
|
WO2025165915A1
(en)
*
|
2024-01-31 |
2025-08-07 |
Adicet Therapeutics, Inc. |
Compositions and methods for enhancing engineered t cell therapies
|
|
WO2025229538A1
(en)
*
|
2024-05-01 |
2025-11-06 |
Janssen Biotech, Inc. |
Materials, methods, and systems for cellular expansion of gamma delta t-cells
|